Paratek Pharmaceuticals Inc SH
13F holders, Q2 2025 (June 30)1holders −1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Paratek Pharmaceuticals Inc SH in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was CHURCHILL MANAGEMENT Corp ($0).
- Company
- Paratek Pharmaceuticals Inc SH
- CUSIP
- 699CVR031
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2025: 10,000 shares bought, net +10,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| CHURCHILL MANAGEMENT Corp | 0.00% | New | 10,000 | $0 |
"% of holder's portfolio" is Paratek Pharmaceuticals Inc SH's weight in each manager's 13F, not the share of Paratek Pharmaceuticals Inc SH the manager owns.